Skip to main content
. 2017 Nov 30;14(5):962–970. doi: 10.5114/aoms.2017.71855

Table III.

Patients on high, moderate, or low doses of different statins either used as monotherapy or in combination with ezetimibe or fenofibrate

Parameter Atorvastatin Fluvastatin Rosuvastatin Simvastatin P-value
Doses of statins High 33 (52.4) 0 (0.0) 80 (64.5) 3 (18.8) < 0.001
Moderate 30 (47.6) 0 (0.0) 44 (35.5) 7 (43.8)
Low 0 (0.0) 1 (100.0) 0 (0.0) 6 (37.5)
Statin monotherapy 29 (46.0) 1 (100.0) 50 (40.3) 11 (68.8) 0.118
Combination therapy Statin + ezetimibe 28 (44.4) 0 (0.0) 68 (54.8) 3 (18.8)
Statin + fenofibrate 6 (9.5) 0 (0.0) 6 (4.8) 2 (12.5)